Rapport mensuel de communication

Nom du déclarant :	Ross Wallace
Client :	Forum canadien des biosimilaires/Canadian Biosimilars Forum
Enregistrement connexe :	929211-358995-3
Date de la communication :	2018-05-22
Date de publication :	2018-06-15

Titulaires d'une charge publique désignée ayant participé à la communication :	Anthony Ridgway, Senior Regulatory Scientist Health Products and Therapeutics Branch, Santé Canada (SC) Cathy Parker, Director General Health Products and Therapeutics Branch, Santé Canada (SC) Evelyn Soo, Associate to the Director General Health Products and Therapeutics Branch, Santé Canada (SC) Johanne Veenstra, Senior Regulatory Officer Health Products and Therapeutics Branch, Santé Canada (SC) Georgette Roy, Director, Office of Regulatory Affairs Health Products and Therapeutics Branch, Santé Canada (SC) Stephanie Hardy, Manager, Policy Unit Health Products and Therapeutics Branch, Santé Canada (SC) Lindsay Elmgren, Director, Centre for Biologics Evaluation Health Products and Therapeutics Branch, Santé Canada (SC) Agnes Klein, Senior Medical Advisor Health Products and Therapeutics Branch, Santé Canada (SC) Emily Griffiths, Subject Matter / Technical Specialist Health Products and Therapeutics Branch, Santé Canada (SC) Jemma Fraije, A/ Regulatory Affairs Supervisor Health Products and Therapeutics Branch, Santé Canada (SC) Megan Bettle, Director Health Products and Therapeutics Branch, Santé Canada (SC) Liz Anne Gillham-Eisen, A Director Health Products and Therapeutics Branch, Santé Canada (SC) Michele Chadwick, Manager Health Products and Therapeutics Branch, Santé Canada (SC) Jian Wang, Division Chief Health Products and Therapeutics Branch, Santé Canada (SC) Karen Reynolds, Executive Director Strategic Policy Branch, Santé Canada (SC) Kelly Robinson, Director Health Products and Therapeutics Branch, Santé Canada (SC)
Objet de la communication :	Santé